Drug Maker To Pay Nearly $520M To Settle SEC, Justice Department FCPA Claims
WASHINGTON, D.C. — Teva Pharmaceutical Industries Ltd. and its wholly owned Russian subsidiary will pay nearly $520 million to settle claims with government authorities over the generic drug manufacturer’s involvement in...To view the full article, register now.
Already a subscriber? Click here to view full article